Literature DB >> 21492563

Computational modeling of HHH therapy and impact of blood pressure and hematocrit.

Joe Sam Robinson1, M Sami Walid, Sinjae Hyun, Robert O'Connell, Chris Menard, Brandi Bohleber.   

Abstract

BACKGROUND: After an aneurysmal subarachnoid hemorrhage, cerebral microcirculatory changes occur as a result cerebral vasospasm. The objective of this study is to investigate, with a computational model, how various degrees of vasospasm are influenced by increasing the mean blood pressure and decreasing the blood viscosity.
METHODS: Using ANSYS CFX software, a computational model was constructed to simulate steady-state fully developed laminar blood flow through a rigid wall system consisting of the internal carotid artery (ICA), anterior cerebral artery, posterior cerebral artery, and middle cerebral artery (MCA). The MCA was selected for the site of a single acute vasospasm. Five severities of vasospasm were studied: 3 mm (normal), 2.5, 2, 1.5, and 1 mm. The ICA was assumed to have a constant inlet flow rate of 315 mL/min. The anterior cerebral artery and posterior cerebral artery were assumed to have constant outlet flow rates of 105 mL/min and 30 mL/min, respectively. The MCA was assumed to have a constant outlet pressure of 92 mL/min. Two different hematocrits, 45% and 32%, were simulated using the models.
RESULTS: For a hematocrit of 45, the mean ICA inlet pressure required to pump blood through the system was 104 mm Hg for the 3-mm diameter MCA and 105, 108, 116, and 158 mm Hg for vasospasm diameters of 2.5, 2, 1.5, and 1 mm, respectively. For a hematocrit of 32, the mean ICA inlet pressure required was 102, 103, 105, 113, and 152 mm Hg, respectively.
CONCLUSIONS: The MCA required a large increase in mean ICA inlet pressure for vasospasm diameters less than 1.5 mm, which suggests that for vasospasms more than 50% diameter reduction, the blood pressure must be increased dramatically. Decreasing the hematocrit had minimal impact on blood flow in a constricted vessel.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21492563     DOI: 10.1016/j.wneu.2010.02.059

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  The Relationship between Pulmonary Dysfunction and Age in Vasospasm Patients Receiving Triple H Therapy.

Authors:  M Sami Walid; Gulnur Sahiner; Donald R Robinson; Joe Sam Robinson
Journal:  J Vasc Interv Neurol       Date:  2011-07

2.  Cerebral vasospasm pharmacological treatment: an update.

Authors:  Ioannis Siasios; Eftychia Z Kapsalaki; Kostas N Fountas
Journal:  Neurol Res Int       Date:  2013-01-31

Review 3.  Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?

Authors:  Young Lee; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.